.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Harvard Business School
Cipla
Dow
Teva
UBS
McKinsey
Baxter
Deloitte
Federal Trade Commission
Fuji

Generated: September 25, 2017

DrugPatentWatch Database Preview

TAGAMET HB 200 Drug Profile

« Back to Dashboard

Which patents cover Tagamet Hb 200, and when can generic versions of Tagamet Hb 200 launch?

Tagamet Hb 200 is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in TAGAMET HB 200 is cimetidine. There are twenty-five drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the cimetidine profile page.

Summary for Tradename: TAGAMET HB 200

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list92
Clinical Trials: see list3,522
Patent Applications: see list4,830
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:TAGAMET HB 200 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline
TAGAMET HB 200
cimetidine
SUSPENSION;ORAL020951-001Jul 9, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Queensland Health
Fuji
US Department of Justice
Mallinckrodt
Boehringer Ingelheim
Federal Trade Commission
Covington
Citi
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot